Genetic Age: A Vision

Email a friend
Contact the editor about this article
How to cite

Genetic Age: A Vision

Thane Kreiner, Affymetrix Inc., Santa Clara, California, USA

Published online: September 2006

DOI: 10.1002/9780470015902.a0005654

Full Article on Wiley Online Library

Abstract
Images
References

Genetic information is transforming research paradigms and spawning new economic trends. Powerful technologies entering the research market have a potential impact upon many industrial segments, ultimately enabling consumers to use genetic information and the consequent understanding of human variation to enhance their quality of life. Societies must proactively address challenges such as privacy and nondiscrimination while ensuring that the Information Age's ‘digital divide’ is not reproduced as a ‘genetic gap’ in the Genetic Age.

Keywords: genetic information; human variation; ‘genetic gap’; GeneChip probe arrays

References
	Bumol TF and Watanabe AM (2001) Genetic information, genomic technologies and the future of drug discovery. Journal of the American Medical Association 285: 551–555.
	Chou WH, Yan F-X, de Leon J, et al. (2000) Impact from the cytochrome p450 2D6 polymorphisms on outcome and costs associated with severe mental illness. Journal of Clinical Psychopharmacology 20: 246–251.
	Collins FS (2001) Contemplating the end of the beginning. Genome Research 11: 641–643.
	Fodor SPA (1997) Massively parallel genomics. Science 277: 393–395.
	Gerhold D, Lu M, Xu J, et al. (2001) Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiological Genomics 5: 161–170.
	Jin H, Yang R, Awad TA, et al. (2001) Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation 103: 736–742.
	Joyce DE, Gelbert L, Ciaccia A, De Hoff B and Grinnell BW (2001) Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. Journal of Biological Chemistry 276: 11199–11203.
	Ly DH, Lockhart DJ, Lerner RA and Schultz PG (2000) Mitotic misregulation and human ageing. Science 287: 2486–2492.
	Pomeroy SL, Tamayo P, Gaasenbeek M, et al. (2002) Gene expression-based classification and outcome prediction of central nervous system embryonal tumors. Nature 415: 436–442.
	Reich DE, Corgill M, Bolk S, et al. (2001) Linkage disequilibrium in the human genome. Nature Genetics 411: 199–204.
Further Reading
	Brooks AJ (1999) The essence of SNPs. Gene 234: 177–186.
	book Buchanan A, Brock DW, Daniels N and Wiler D (2000) From Chance to Choice. Cambridge, UK: Cambridge University Press.
	Clayton EW (2001) Through the lens of the sequence. Genome Research 11: 659–664.
	Collins FS and McKusick VA (2001) Implications of the Human Genome Project for medical science. Journal of the American Medical Association 285: 540–544.
	Fodor SPA, Read JL, Pirrung MC, et al. (1991) Light-directed, spatially addressable parallel chemical synthesis. Science 251: 767–773.
	Fuller BP, Ellis Kahn MJ, et al. (1999) Privacy in genetics research. Science 285: 1359–1361.
	Moore GE (1965) Cramming more components onto integrated circuits. Electronics 38(8).
	book Silver L (1998) Remaking Eden: How Genetic Engineering and Cloning will Transform the American Family. New York, NY: Avon Books.
	Various authors (2001) The human genome [special issue]. Nature 409: 745–964.
	Various authors (2001) The human genome [special issue]. Science 291: 1145–1434.

Article Title:	Genetic Age: A Vision
* Name:
* E-mail:
* Note:

	Figure 1. Availability of sequence information from the human and other genomes enables the creation of genetic information analysis tools. These in turn allow scientists to access information for studies in a variety of life sciences.
	Figure 2. Commercial DNA arrays are individually packaged (a) for use by scientists in their own laboratories. Standard products contain up to 500000 features on a 1.25 cm² chip (b), and each 18 µm×18 µm feature contains millions of copies of the same oligonucleotide probe (c), which bind to complementary sequences in the target (sample).
	Figure 3. Genetic information can be applied throughout the drug discovery and development process to identify and harness new therapeutic strategies. (After Bumol TF and Watanabe AM (2001) Journal of the American Medical Association 285: 551–555.)

Genetic Age: A Vision

Related Sub-Topics: